The pharmaceutical industry seems besieged on all sides by declining R&D productivity, expiring patents and relentless downward pricing pressure. One effect of this onslaught has been an upsurge in the level of consolidation as industry players attempt to cut costs, expand research pipelines and lengthen geographic reach.
17-Oct-2013 - US contractor DPT says it has received calls from customers of soon-to-close CMO Ben Venue Labs.
10-Oct-2013 - Catalent has continued its softgel expansion in emerging markets with the acquisition of Relthy Laboratórios in Brazil.
10-Oct-2013 - McKesson Corporation who is said to be in talks to acquire German logistics company Celesio has appointed a new CFO and Executive Director - Welcome to Outsourcing-Pharma's People on the Move....
08-Oct-2013 - AAIPharma says the merger with Cambridge Major Laboratories (CML) will bring clients the benefits of integrated Chemistry and Manufacturing Controls (CMC) services from two high-growth CMOs.
26-Sep-2013 - WCCT Global has acquired OC Clinical Trials & Consulting to boost its early-stage ophthalmology services and fill a gap in the market, the firm says.
25-Sep-2013 - The merger of PRA and RPS has been completed, creating the fourth largest contract research organisation (CRO).
24-Sep-2013 - Molecular Profiles has been chosen to develop topical and solid dose formulations of a preclinical psoriasis treatment as part of a multicompany conglomerate led by Telormedix.
17-Sep-2013 - Recent entrant into the formulation services sector Columbia Laboratories has added Molecular Profiles execs to its board.
10-Sep-2013 - The CMO market remains highly fragmented with thirty percent of active players likely to exit the business in the next ten years, according to a Frost & Sullivan report.
09-Sep-2013 - Patheon has reported increased revenue growth for Q3 2013 following the full completion of Banner and says more industry consolidation is likely.
30-Jul-2013 - US CRO Crown BioSciences has acquired Precos citing the UK contractor’s preclinical oncology services and presence in the European market as the key drivers.
25-Jul-2013 - Clinical Research Advantage (CRA) has acquired the late phase business of Comprehensive Clinical Development (CCD) adding psychiatric clinical trials to its services.
05-Mar-2013 - US CRO PRA international has expanded its presence in Eastern Europe with the acquisition of privately-owned trial services firm ClinStar.
29-Jan-2013 - Quintiles and investor TPG Capital declined to comment on rumours the CRO is sizing up banks and preparing for an IPO.
20-Nov-2012 - Medpace has acquired Meditech Strategic Consulting in a bid to expand its European clinical trial services.
14-Nov-2012 - A new personalised medicine-focused partnership for AstraZeneca, expansion in three continents for World Wide clinical and six small CROs team-up to create one super-team. Outsourcing-pharma.com presents a round-up of the...
08-Nov-2012 - Outsourcing-Pharma.com is in Hamburg,Germany this week to meet the CROs, sponsors and academics gathered at PCT Europe to discuss the future of partnerships in clinical trials.
05-Nov-2012 - Eli Lilly is bringing more production in-house after investing $140m in the expansion of its US insulin site.
23-Oct-2012 - Xcelience is shopping for a European distributor after opening a new clinical trial supply facility in the US.
15-Oct-2012 - Piramal Healthcare wants to add sterile injectables to its offering but is unwilling to overpay for facilities owned by 'value focused' private equity groups.
25-Sep-2012 - Clinipace has bought Californian CRO Paragon Biomedical in a bid to expand its therapeutic expertise.
24-Sep-2012 - Carestream Health has offloaded most of its preclinical molecular imaging systems in a deal with Bruker.
20-Sep-2012 - Quintiles has granted Comprehensive Clinical Development first refusal to work on its sponsored clinical trials.
11-Sep-2012 - Isotope technology firm Eckert & Ziegler has acquired bioanalytical CRO Vitalea Science.
06-Sep-2012 - Improving efficiency in biopharma research is a “mixed blessing” for contract research organisations (CROs), according to Wells Fargo.